Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F952BD48.svg?ark=w1%2F20260515%2FF952BD48)](https://nobleid.org/work/w1/20260515/F952BD48)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors